apollomicsinc.com
Get leads like Apollomicsinc — and thousands more
Build targeted lists by tech stack, traffic, and more
Apollomics: The $239M Bet on Oncology
A deep dive into a well-funded biotech with a lean operation and high stakes.
In the high-stakes world of oncology biotech, Apollomics isn't just chasing a single drug—it's engineering combination therapies to outmaneuver cancer itself. With $239M in funding, the pressure is on to deliver.
"With only 31 employees and $239M in the bank, Apollomics is running a capital-efficient sprint in a marathon-length industry."
The Lean Biotech Machine
The team is microscopic compared to the funding. At 31 employees, the burn rate per head is aggressive. The leadership is anchored by heavy hitters: Guo-Liang Yu (CEO) and Matthew Plunkett (CFO). Their site traffic is modest (3,693 monthly visits), but highly direct (44%), suggesting a focused investor and professional audience rather than broad consumer appeal.
The Traffic Anomaly
The traffic data reveals a peculiar narrative. 65% of traffic is undefined, followed by 26.9% and 7.8%. This suggests either heavy bot activity, privacy-focused visitors, or a fragmented analytics setup. The top keywords are telling: 'reverse split shareholder special meeting rounding up' (760 volume) indicates active shareholder management, a sign of a public or pre-IPO entity navigating corporate actions.
Apollomics operates in the 'discovery and development' phase, meaning they are pre-commercial. The $2.4M revenue likely stems from grants, partnerships, or early licensing, not product sales. Their tech stack—jQuery, Tailwind, Bootstrap—is surprisingly standard for a biotech, lacking the custom, high-end digital experiences often seen in well-funded startups, which implies a focus on product over web presence.
- Core Focus: Oncology combination therapies (targeting cancer resistance).
- Key Leadership: Guo-Liang Yu (Co-Founder/CEO) and Matthew Plunkett (CFO).
- Digital Footprint: Low traffic volume but high direct intent.
- Funding Efficiency: $7.7M funding per employee ratio.
The Verdict: A High-Risk, High-Reward Play
Apollomics is a classic biotech play: heavy funding, lean execution, and binary clinical outcomes. The website is a corporate brochure, not a growth engine, but the science could be the real value driver.
What tech stack does Apollomicsinc use?
How much traffic does Apollomicsinc get?
Traffic & Engagement
Traffic Sources
Where is Apollomicsinc's audience located?
What keywords does Apollomicsinc rank for?
5 keywordsHow is Apollomicsinc's SEO?
Open Graph Image
https://www.apollomicsinc.com/wp-content/uploads/2023/05/apollomics_aplm_social_logo.png
Meta Tags
Apollomics, Inc. - Committed to the discovery and development of oncology combination therapies
Committed to the discovery and development of oncology combination therapies
H1 Tags
Schema Types
What is Apollomicsinc's revenue?
Who competes with Apollomicsinc?
Who works at Apollomicsinc?
Loading leads...
What do customers think of Apollomicsinc?
No Trustpilot reviews available for this company.
Frequently Asked Questions about Apollomicsinc
What is Apollomicsinc's Revenue?
What does Apollomicsinc do?
How fast is Apollomicsinc growing?
What technologies does Apollomicsinc use?
Who are Apollomicsinc's competitors?
Export Data
Unlock all exports
Download CSVs, JSONs & full reports
How to contact Apollomicsinc?
Contact Information
Export apollomicsinc.com Data
Download the complete tech stack, analytics, leads, and company data for apollomicsinc.com in JSON or CSV format. Use it for your sales pipeline, competitive analysis, or research.
Raw JSON Data
Click "Show" to view the raw API response data
About apollomicsinc.com
Committed to the discovery and development of oncology combination therapies
Company Overview
apollomicsinc.com Social Media
Contact apollomicsinc.com
Phone Numbers
Technology Stack
apollomicsinc.com uses 15 technologies across their website including Font Awesome, Google Fonts, PHP, WordPress, and more.
Fonts
Font Awesome, Google Fonts
Programming Languages
PHP
CMS
WordPress
Cloud & Hosting
Cloudflare
Analytics & Marketing
Google Analytics
Performance
Lazy Loading, Priority Hints
Traffic & Audience
apollomicsinc.com receives approximately 3.7K monthly visitors and ranks #4,243,520 globally. The website has a bounce rate of 35% with visitors viewing an average of 2.2 pages per visit. Users spend an average of 0:31 on the site.
The majority of apollomicsinc.com's traffic comes from undefined, undefined, .
Frequently Asked Questions
What is apollomicsinc.com?
What technologies does apollomicsinc.com use?
How do I contact apollomicsinc.com?
What are apollomicsinc.com's social media accounts?
Is apollomicsinc.com hiring?
How popular is apollomicsinc.com?
Related Searches
This page provides publicly available information about apollomicsinc.com. Data is collected from various public sources and may not always be up to date. For the most accurate information, please visit apollomicsinc.com directly at https://apollomicsinc.com.